These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 35118583

  • 1. Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome.
    Ono T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Akiyama T, Sugaya J, Fukushima S, Kojima N, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2022 Mar; 35(2):756-766. PubMed ID: 35118583
    [Abstract] [Full Text] [Related]

  • 2. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
    Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Akiyama T, Sugaya J, Nakatani F, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2022 Jan; 35(1):384-391. PubMed ID: 34665443
    [Abstract] [Full Text] [Related]

  • 3. Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma.
    Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.
    In Vitro Cell Dev Biol Anim; 2018 Mar; 54(3):257-263. PubMed ID: 29359268
    [Abstract] [Full Text] [Related]

  • 4. Establishment and characterization of NCC-PS1-C1: a novel cell line of pleomorphic sarcoma from a patient after neoadjuvant radiotherapy.
    Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Sugaya J, Kobayashi E, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2022 Nov; 35(6):2011-2019. PubMed ID: 36103079
    [Abstract] [Full Text] [Related]

  • 5. Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone.
    Ono T, Noguchi R, Yoshimatsu Y, Tsuchiya R, Sin Y, Nakagawa R, Hirabayashi K, Ozawa I, Kikuta K, Kondo T.
    Hum Cell; 2022 Jan; 35(1):392-399. PubMed ID: 34731453
    [Abstract] [Full Text] [Related]

  • 6. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma.
    Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Fukushima S, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2020 Oct; 33(4):1302-1310. PubMed ID: 32648033
    [Abstract] [Full Text] [Related]

  • 7. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.
    Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T.
    Hum Cell; 2020 Apr; 33(2):427-436. PubMed ID: 31898195
    [Abstract] [Full Text] [Related]

  • 8. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone.
    Ono T, Noguchi R, Yoshimatsu Y, Sin Y, Tsuchiya R, Akiyama T, Kojima N, Toda Y, Sato C, Fukushima S, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2023 Sep; 36(5):1804-1812. PubMed ID: 37328637
    [Abstract] [Full Text] [Related]

  • 9. Establishment and characterization of NCC-PLPS1-C1, a novel patient-derived cell line of pleomorphic liposarcoma.
    Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T.
    Hum Cell; 2021 Mar; 34(2):688-697. PubMed ID: 33205363
    [Abstract] [Full Text] [Related]

  • 10. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.
    Kito F, Oyama R, Sakumoto M, Shiozawa K, Qiao Z, Toki S, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2019 Apr; 32(2):214-222. PubMed ID: 30737712
    [Abstract] [Full Text] [Related]

  • 11. Establishment and characterization of NCC-MFS3-C1: a novel patient-derived cell line of myxofibrosarcoma.
    Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Sei A, Takeshita F, Sugaya J, Iwata S, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2021 Jul; 34(4):1266-1273. PubMed ID: 33990915
    [Abstract] [Full Text] [Related]

  • 12. Establishment and characterization of NCC-PLPS2-C1: a novel cell line of pleomorphic liposarcoma.
    Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Osaki J, Adachi Y, Ono T, Tsuchiya R, Sato C, Iwata S, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2023 Jan; 36(1):468-475. PubMed ID: 36436139
    [Abstract] [Full Text] [Related]

  • 13. Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1.
    Adachi Y, Noguchi R, Osaki J, Ono T, Iwata S, Akiyama T, Tsuchiya R, Toda Y, Tetsuya S, Iwata S, Kobayashi E, Kojima N, Yoshida A, Yokoo H, Kawai A, Kondo T.
    Hum Cell; 2024 Nov; 37(6):1742-1750. PubMed ID: 39214957
    [Abstract] [Full Text] [Related]

  • 14. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma.
    Yoshimatsu Y, Noguchi R, Osaki J, Sin Y, Tsuchiya R, Ono T, Akiyama T, Adachi Y, Tanzawa Y, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2024 Jan; 37(1):337-344. PubMed ID: 37907774
    [Abstract] [Full Text] [Related]

  • 15. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
    Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Sei A, Takeshita F, Sugaya J, Nakatani F, Yoshida A, Ohtori S, Kawai A, Kondo T.
    Hum Cell; 2021 Sep; 34(5):1569-1578. PubMed ID: 34164773
    [Abstract] [Full Text] [Related]

  • 16. Establishment and characterization of NCC-LMS2-C1-a novel patient-derived cancer cell line of leiomyosarcoma.
    Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T.
    Hum Cell; 2021 Jan; 34(1):279-288. PubMed ID: 33001379
    [Abstract] [Full Text] [Related]

  • 17. Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma.
    Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T.
    Hum Cell; 2021 Jan; 34(1):246-253. PubMed ID: 32870449
    [Abstract] [Full Text] [Related]

  • 18. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma.
    Osaki J, Noguchi R, Yanagihara K, Ono T, Adachi Y, Iwata S, Toda Y, Sekita T, Kobayashi E, Kojima N, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2024 May; 37(3):865-873. PubMed ID: 38478355
    [Abstract] [Full Text] [Related]

  • 19. Establishment and characterization of a novel alveolar rhabdomyosarcoma cell line, NCC-aRMS1-C1.
    Sin Y, Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Ono T, Toki S, Kobayashi E, Arakawa A, Sugiyama M, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2020 Oct; 33(4):1311-1320. PubMed ID: 32715445
    [Abstract] [Full Text] [Related]

  • 20. Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma.
    Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Iwata S, Yoshida A, Kawai A, Kondo T.
    Hum Cell; 2020 Jul; 33(3):877-885. PubMed ID: 32274656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.